Group B streptococcus; Non-pregnant adults; Invasive infections; Incidence; Serotypes; Vaccine; Obesity
Abstract :
[en] To assess the incidence, clinical, microbiological features and outcome of invasive Streptococcus agalactiae (GBS) infections in non-pregnant adults in three tertiary hospitals of the Brussels-Capital Region. All bacterial cultures positive for GBS, from 2005 to 2019 from 3 hospitals of the Brussels-Capital Region, were extracted, and only cases of invasive diseases were included. Medical files were retrospectively retrieved for risk factors, clinical manifestations and outcome and also antibiotic-susceptibility testing and GBS serotypes. Incidence rates were calculated based on the hospitals catchment populations. A total of 337 cases of GBS-invasive infections were included. The incidence of invasive GBS for the 3 hospitals increased from 3.7 to 8.2 cases per 100.000 inhabitants between 2009 and 2018 (p = 0.04). The most frequently identified risk factors were diabetes (36.8%), obesity (35.0%), cancer (21.7%), renal disease (20.8%), and advanced age (≥ 65 years; 47.2%). Isolated bacteremia (22%), osteoarticular infection (21.4%), abscesses (13.9%), and skin and soft tissue infections (18.4%) were the most frequent manifestations. Intensive care unit admission was required in 21.7% and overall mortality was 9.4%. All strains remained susceptible to penicillin over the years. Up to 20% of strains were resistant to clindamycin. Serotypes Ia, Ib, II, III, IV, and V represented 96.8% of the available serotypes (60/62). As reported in several countries, invasive GBS disease in non-pregnant adults represents an increas- ing burden, particularly among diabetic, obese, and elderly patients. Almost all serotypes identified are included in the upcoming hexavalent GBS conjugate vaccine.
Disciplines :
Laboratory medicine & medical technology Immunology & infectious disease
Pimentel BAS, Martins CAS, Mendonça JC, Miranda PSD, Sanches GF, Mattos-Guaraldi AL et al (2016) Streptococcus agalactiae infection in cancer patients: a five-year study. Eur J Clin Microbiol Infect Dis 35:927–933. 10.1007/s10096-016-2617-9 DOI: 10.1007/s10096-016-2617-9
Barshak MB (2019) Group B Streptococcus, an A-list pathogen in nonpregnant adults. JAMA Intern Med 179:488. 10.1001/jamainternmed.2018.7296 DOI: 10.1001/jamainternmed.2018.7296
Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J et al (2017) Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis 65:S100–S111. 10.1093/cid/cix658 DOI: 10.1093/cid/cix658
Hasperhoven G, Al-Nasiry S, Bekker V, Villamor E, Kramer B (2020) Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol 127:680–691. 10.1111/1471-0528.16085 DOI: 10.1111/1471-0528.16085
Rantz LA (1940) Suppurative arthritis due to a hemolytic streptococcus of the lancefield group B: a case report. Ann Intern Med 1(13):1744. 10.7326/0003-4819-13-9-1744
Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T et al (2019) Epidemiology of invasive group B Streptococcal infections among nonpregnant adults in the United States, 2008-2016. JAMA Intern Med 179:479. 10.1001/jamainternmed.2018.7269 DOI: 10.1001/jamainternmed.2018.7269
Björnsdóttir ES, Martins ER, Erlendsdóttir H, Haraldsson G, Melo-Cristino J, Kristinsson KG et al (2016) Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014. Clin Microbiol Infect 22:379.e9–379.e16. 10.1016/j.cmi.2015.11.020 DOI: 10.1016/j.cmi.2015.11.020
Martins ER, Melo-Cristino J, Ramirez M (2012) The Portuguese group for the study of Streptococcal infections. Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal. J Clin Microbiol 50:1219–1227. 10.1128/JCM.05488-11 DOI: 10.1128/JCM.05488-11
Tazi A, Morand PC, Réglier-Poupet H, Dmytruk N, Billoët A, Antona D et al (2011) Invasive group B streptococcal infections in adults, France (2007–2010). Clin Microbiol Infect 17:1587–1589. 10.1111/j.1469-0691.2011.03628.x DOI: 10.1111/j.1469-0691.2011.03628.x
Collin SM, Shetty N, Lamagni T (2020) Invasive group B streptococcus infections in adults, England, 2015–2016. Emerg Infect Dis 26:1174–1181. 10.3201/eid2606.191141 DOI: 10.3201/eid2606.191141
High KP, Edwards MS, Baker CJ (2005) Group B streptococcal infections in elderly adults. Clin Infect Dis 41:839–847. 10.1086/432804 DOI: 10.1086/432804
Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N et al (2008) First Molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890–2897. 10.1128/AAC.00185-08 DOI: 10.1128/AAC.00185-08
McGee L, Chochua S, Li Z, Mathis S, Rivers J, Metcalf B et al (2020) Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive group B streptococci within the United States, 2015–2017. Clin Infect Dis 15:ciaa151. 10.1093/cid/ciaa151 DOI: 10.1093/cid/ciaa151
Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM et al (2008) Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008:1–5. 10.1155/2008/727505 DOI: 10.1155/2008/727505
Sacheli R, Melin P (2016) Rapport d’activités du Centre National de Référence du Streptococcus agalactiae
Buurman ET, Timofeyeva Y, Gu J, Kim J, Kodali S, Liu Y et al (2019) A Novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization. J Infect Dis 220:105–115. 10.1093/infdis/jiz062 DOI: 10.1093/infdis/jiz062
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. 10.1016/j.jbi.2008.08.010 DOI: 10.1016/j.jbi.2008.08.010
Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251. 10.1016/0895-4356(94)90129-5 DOI: 10.1016/0895-4356(94)90129-5
Melin, P. Evaluation externe de la qualité des analyses en biologie clinique. Rapport de microbiologie enquête 02/2005. Partim Streptococcus agalactiae [Internet]. 2005 [cited 2020 7];doi: https://www.wiv-isp.be/QML/activities/external_quality/rapports/_down/microbiologie/2005/05-2F-MICROBIO.pdf
Poyart C, Tazi A, Reglier-Poupet H, Billoet A, Tavares N, Raymond J et al (2007) Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 45:1985–1988. 10.1128/JCM.00159-07 DOI: 10.1128/JCM.00159-07
Kong F, Lambertsen LM, Slotved H-C, Ko D, Wang H, Gilbert GL (2008) Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci. J Clin Microbiol 46:2745–2750. 10.1128/JCM.00189-08 DOI: 10.1128/JCM.00189-08
RHM: Parts de marché des hôpitaux par commune de résidence des patients et classe d’âge [Internet]. [cited 2020 12];doi: https://www.health.belgium.be/fr/rhm-parts-de-marche-des-hopitaux-par-commune-de-residence-des-patients-et-classe-dage DOI: https://www.health.belgium.be/fr/rhm-parts-de-marche-des-hopitaux-par-commune-de-residence-des-patients-et-classe-dage
Jump RLP, Wilson BM, Baechle D, Briggs JM, Banks RE, Song S et al (2019) Risk factors and mortality rates associated with invasive group B Streptococcus infections among patients in the US Veterans Health Administration. JAMA Netw Open 27(2):e1918324. 10.1001/jamanetworkopen.2019.18324 DOI: 10.1001/jamanetworkopen.2019.18324
Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K et al (2013) Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991–2010. Clin Infect Dis 57:682–688. 10.1093/cid/cit337 DOI: 10.1093/cid/cit337
Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K et al (2009) Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis 49:85–92. 10.1086/599369 DOI: 10.1086/599369
Sacheli R, Meex C, Melin P, Descy J, Huynen P, Hayette M-P. Surveillance of group B streptococcus (GBS) strains isolated from invasive diseases among adults in Belgium: Bacteriological and clinical characteristics. [Internet]. 2018 [cited 2020 7];doi: http://hdl.handle.net/2268/223202
Centers for Disease Control and Prevention. 2016. Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2016. 2018 20; https://www.cdc.gov/abcs/reports-findings/survreports/spneu16.pdf
Santé Publique France. Bilan annuel 2018: Impact de la vaccination par le vaccin pneumococcique conjugué 13-valent (VPC13) sur l’incidence des infections invasives à pneumocoques. Données du réseau Epibac et du CNR des pneumocoques (réseau CNRP-ORP) [Internet]. [cited 2020 12]; https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infections-a-pneumocoque/donnees/#tabs
Cardoso T, Almeida M, Friedman ND, Aragão I, Costa-Pereira A, Sarmento AE et al (2014) Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 12:40. 10.1186/1741-7015-12-40 DOI: 10.1186/1741-7015-12-40
Collin SM, Lamb P, Jauneikaite E, Le Doare K, Creti R, Berardi A et al (2019) Hospital clusters of invasive group B streptococcal disease: a systematic review. J Infect 79:521–527. 10.1016/j.jinf.2019.11.008
Heath PT, Culley FJ, Jones CE, Kampmann B, Le Doare K, Nunes MC et al (2017) Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. Lancet Infect Dis 17:e223–e234. 10.1016/S1473-3099(17)30232-3 DOI: 10.1016/S1473-3099(17)30232-3
Dauby N (2019) Vaccination for the prevention of group B Streptococcus infection in nonpregnant adults. JAMA Intern Med 179:998. 10.1001/jamainternmed.2019.1590 DOI: 10.1001/jamainternmed.2019.1590
